Gu, Y.; Xue, M.; Wang, Q.; Hong, X.; Wang, X.; Zhou, F.; Sun, J.; Wang, G.; Peng, Y.
Novel Strategy of Proxalutamide for the Treatment of Prostate Cancer through Coordinated Blockade of Lipogenesis and Androgen Receptor Axis. Int. J. Mol. Sci. 2021, 22, 13222.
https://doi.org/10.3390/ijms222413222
AMA Style
Gu Y, Xue M, Wang Q, Hong X, Wang X, Zhou F, Sun J, Wang G, Peng Y.
Novel Strategy of Proxalutamide for the Treatment of Prostate Cancer through Coordinated Blockade of Lipogenesis and Androgen Receptor Axis. International Journal of Molecular Sciences. 2021; 22(24):13222.
https://doi.org/10.3390/ijms222413222
Chicago/Turabian Style
Gu, Yue, Mengxia Xue, Qizhi Wang, Xiaodan Hong, Xinyu Wang, Fang Zhou, Jianguo Sun, Guangji Wang, and Ying Peng.
2021. "Novel Strategy of Proxalutamide for the Treatment of Prostate Cancer through Coordinated Blockade of Lipogenesis and Androgen Receptor Axis" International Journal of Molecular Sciences 22, no. 24: 13222.
https://doi.org/10.3390/ijms222413222
APA Style
Gu, Y., Xue, M., Wang, Q., Hong, X., Wang, X., Zhou, F., Sun, J., Wang, G., & Peng, Y.
(2021). Novel Strategy of Proxalutamide for the Treatment of Prostate Cancer through Coordinated Blockade of Lipogenesis and Androgen Receptor Axis. International Journal of Molecular Sciences, 22(24), 13222.
https://doi.org/10.3390/ijms222413222